NRG2 and central nervous system cancer: Upon looking into the copy number loss of NRG2, NRG3, and BTC in glioma cell lines from CCLE, we found that no copy number loss was observed across glioma cell lines for NRG2 and BTC and copy number loss of NRG3 occurred in approximately 12% of glioma cell lines.